Hypotony in Patients with Uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial
Hypotony in Patients with Uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial
复制标题
DOI：
10.3109/09273948.2011.647228
复制
发表时间：
2012-04-01
影响因子：
3.3
通讯作者：
Jabs, Douglas A.
中科院分区：
文献类型：
--
作者：
Sen, H. Nida;Drye, Lea T.;Jabs, Douglas A.
Purpose: To assess the prevalence of hypotony in patients with severe forms of uveitis.Methods: The Multicenter Uveitis Steroid Treatment (MUST) Trial, a randomized study, enrolled 255 patients. Patients with hypotony at the baseline visit were identified.Results: Twenty (8.3%) of 240 patients with sufficient data had hypotony. Hypotony was more common in patients with uveitis >= 5 years duration (odds ratio [OR] = 5.0; p < .01), and in eyes with a history of ocular surgery (vitrectomy vs. none, OR = 3.1; p = .03). Hypotony was less in patients with older age of uveitis onset (>51 years vs. < 51 years, OR = 0.1; p = .02), in Caucasian patients (OR = 0.1; p < .01) compared to African American patients. Hypotonous eyes were more likely to have visual impairment (OR = 22.9; p < .01).Conclusions: Hypotony is an important complication of uveitis and more commonly affects African-American patients, those with uveitis onset at a younger age, and those with longer disease duration. It is associated with visual impairment.
